Georgina V Long Selected Research

Georgina V Long Research Topics

Disease

293	Melanoma (Melanoma, Malignant) 12/2022 - 04/2011
119	Neoplasms (Cancer) 10/2022 - 03/2012
52	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2012
25	Brain Neoplasms (Brain Tumor) 10/2022 - 03/2012
22	Disease Progression 11/2021 - 11/2012
11	Fever (Fevers) 01/2021 - 11/2012
6	Lymphatic Metastasis 01/2022 - 01/2019
6	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 02/2016
5	Body Weight (Weight, Body) 10/2019 - 01/2015
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2015 - 04/2014
4	Inflammation (Inflammations) 01/2022 - 01/2017
4	Pneumonia (Pneumonitis) 01/2022 - 01/2017
4	Uveal melanoma 04/2021 - 01/2020
4	Colitis 01/2021 - 01/2019
4	Fatigue 01/2019 - 01/2015
3	Neutropenia 01/2021 - 11/2012
3	Nevus (Nevi) 01/2019 - 07/2012
2	COVID-19 01/2022 - 01/2021
2	Thyrotoxicosis 01/2022 - 01/2021
2	Hypothyroidism 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2019
2	Hepatitis 11/2021 - 01/2021
2	Infections 01/2021 - 11/2018
2	Hypophysitis 06/2018 - 08/2014
2	Pain (Aches) 10/2015 - 05/2015
2	Nausea 05/2015 - 01/2015
2	Carcinogenesis 12/2012 - 07/2012
1	Facial Nerve Diseases (Facial Nerve Disorders) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

59	Immune Checkpoint InhibitorsIBA 05/2022 - 02/2015
58	dabrafenibIBA 01/2022 - 01/2012
54	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2022 - 11/2012
48	IpilimumabIBA 10/2022 - 01/2013
48	trametinibIBA 01/2022 - 11/2012
40	pembrolizumabIBA 01/2022 - 06/2015
36	NivolumabIBA 12/2022 - 01/2015
33	Biomarkers (Surrogate Marker)IBA 06/2022 - 05/2012
20	VemurafenibIBA 01/2018 - 03/2012
18	Pharmaceutical PreparationsIBA 01/2020 - 05/2012
17	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 01/2013
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
12	AntibodiesIBA 01/2022 - 09/2013
11	LigandsIBA 10/2022 - 07/2015
11	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 03/2016
9	B7-H1 AntigenIBA 01/2022 - 03/2014
9	Circulating Tumor DNAIBA 01/2022 - 12/2015
9	Dacarbazine (DIC)FDA LinkGeneric 11/2020 - 01/2012
9	Phosphotransferases (Kinase)IBA 01/2020 - 12/2014
8	Mitogen-Activated Protein KinasesIBA 10/2022 - 01/2012
8	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
7	Formaldehyde (Formol)FDA Link 01/2022 - 01/2013
7	SteroidsIBA 11/2021 - 10/2014
6	Biological ProductsIBA 10/2022 - 12/2015
6	ParaffinIBA 01/2022 - 01/2013
6	CytokinesIBA 01/2022 - 03/2014
5	Monoclonal AntibodiesIBA 01/2022 - 01/2017
5	CateninsIBA 12/2017 - 01/2014
5	Proto-Oncogene Proteins B-rafIBA 09/2015 - 09/2013
4	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 10/2014
4	Programmed Cell Death 1 ReceptorIBA 01/2022 - 11/2018
4	Cell-Free Nucleic AcidsIBA 11/2020 - 09/2013
3	relatlimabIBA 12/2022 - 01/2022
3	spartalizumabIBA 01/2022 - 10/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2019
3	MART-1 AntigenIBA 12/2021 - 09/2013
3	GlucocorticoidsIBA 11/2021 - 11/2020
3	CTLA-4 AntigenIBA 10/2020 - 03/2014
3	EnzymesIBA 01/2019 - 01/2017
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 03/2014
2	Dihydrotachysterol (AT 10)IBA 11/2022 - 01/2021
2	AntigensIBA 10/2022 - 11/2020
2	bempegaldesleukinIBA 03/2022 - 10/2020
2	Interleukin-2 (IL2)IBA 01/2022 - 06/2014
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2021 - 06/2018
2	atezolizumabIBA 01/2021 - 01/2018
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021 - 11/2020
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 10/2014
2	ChemokinesIBA 01/2020 - 03/2014
2	PlacebosIBA 01/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 04/2014
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 07/2015
2	tributyl phosphate (TBP)IBA 11/2017 - 10/2014
2	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 07/2015 - 04/2014
1	2- (5- (3- chlorophenyl)- 6- (4- chlorophenyl)- 1- (1- (isopropylsulfonyl)- 3- methylbutan- 2- yl)- 3- methyl- 2- oxopiperidin- 3- yl)acetic acidIBA 10/2022
1	Bispecific AntibodiesIBA 10/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022

Therapy/Procedure

174	Therapeutics 10/2022 - 04/2011
78	Immunotherapy 10/2022 - 09/2012
17	Drug Therapy (Chemotherapy) 04/2022 - 01/2012
9	Radiotherapy 01/2022 - 01/2013
7	Lymph Node Excision (Lymph Node Dissection) 10/2022 - 01/2019
7	Neoadjuvant Therapy 08/2022 - 01/2019
3	Aftercare (After-Treatment) 05/2022 - 03/2012
2	Retreatment 01/2021 - 01/2018
2	Precision Medicine 02/2016 - 12/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2022